Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$4.4MFederal grants as PI9 awards
3Patents grantedLatest Aug 19, 2025
1,172Papers52,780 citations
Federal awards and patents by year
AwardsPatents
9 awards · $4.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 31, 2020 | NIH | SBIR Phase II Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia | $557K | BIOFLUIDICA, INC. |
| Sep 18, 2019 | NIH | SBIR Phase II Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia | $838K | BIOFLUIDICA, INC. |
| May 1, 2019 | NIH | SBIR Phase I A microfluidic platform for the high-throughput isolation circulating fetal trophoblasts for non-invasive prenatal testing | $292K | BIOFLUIDICA, INC. |
| Apr 19, 2019 | NIH | SBIR Phase I A microfluidic platform for the high-throughput isolation circulating fetal trophoblasts for non-invasive prenatal testing | $292K | BIOFLUIDICA, INC. |
| Sep 18, 2018 | NIH | SBIR Phase I Parallel and high throughput isolation of cfDNA to target detection of rare, highly conserved nucleotide polymorphisms | $287K | BIOFLUIDICA, INC. |
| Jul 18, 2018 | NIH | SBIR Phase II Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia | $349K | BIOFLUIDICA, INC. |
| Jul 13, 2018 | NIH | SBIR Phase I Parallel and high throughput isolation of cancer cell derived extracellular vesicles | $239K | BIOFLUIDICA, INC. |
| Feb 21, 2018 | NIH | SBIR Phase II Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood | $712K | BIOFLUIDICA, INC. |
| Feb 23, 2017 | NIH | SBIR Phase II Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood | $798K | BIOFLUIDICA, INC. |
4 patents as inventor
- US 11865541BIOFLUIDICA, INC.Jan 9, 2024
- US 12350669BIOFLUIDICA, INC.Jul 8, 2025
- US 12390805BIOFLUIDICA, INC.Aug 19, 2025
- US BIOFLUIDICA, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#364
Awards as PI#166
Patents#124
Companies
- BIOFLUIDICA, INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.